Molecular Targeting Technologies, Inc. And National Health Research Institutes Present A Novel Cancer Therapeutic At 2015 American Association for Cancer Research

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI), Taiwan announced today that they will present results on a new cancer therapeutic at the American Association of Cancer Research conference (AACR) in Philadelphia. This small molecule drug conjugate has successfully achieved proof-of-concept in preclinical models and is now moving toward the next major milestone, which is the production of a drug product for non-clinical and clinical studies.

Help employers find you! Check out all the jobs and post your resume.